being and becoming in the world
This Wednesday, Professor John Krystal, Yale University, has been invited by BAP to give this talk: ‘Linking depression pathophysiology to the mechanism of action of ketamine and “next generation” treatments’ … Continue reading BAP Summer Meeting 2024: Guest Lecture
This BAP educational session is funded by Boehringer Ingelheim. It takes place on Tuesday 23rd July.
This CME session for BAP takes place on Monday. The session is chaired by Dr Sameer Jauhar: BAP provides this summary of the session: Several contributors to this BAP session … Continue reading BAP Summer Meeting: “50 years of hurt?”
This is one of tomorrow’s educational sessions at the BAP Summer Meeting: BAP provide this summary for tomorrows CME meeting: Contributing to this CME meeting: Professor Guy Goodwin is a … Continue reading BAP: Advancing psychopharmacology
There is less than 2 weeks to go till the 2024 Summer Meeting of the British Association for Psychopharmacology [BAP]. This year it is being held in Birmingham. As ever, … Continue reading BAP! It’s boom time in industry!
Published 21 May 2024 BMJ 2024;385:e076797 Ravi Gupta, assistant professor of medicine Reshma Ramachandran, assistant professor of medicine Joseph S Ross, professor of medicine and health policy Ravi Gupta and … Continue reading Tackling the excesses of pharmaceutical marketing and promotion
Chaired the Expert committee which “recommended that the use of depression symptom questionnaires be financially incentivised” The title image is based on declarations made by Professor Tony Kendrick in his … Continue reading Chaired the expert committee which recommended . . .
In the USA, pharmaceutical and medical device companies are required by law to release details of their payments to a variety of doctors and U.S. teaching hospitals for promotional talks, … Continue reading Learning from the USA